When you share your commitment to Parkinson's Foundation in your estate or financial plan, you become an honored member of our Legacy Society. The Legacy Society recognizes and honors all individuals who provide support for Parkinson's Foundation in their wills, trusts, life income gifts, retirement plans, life insurance designations, and other planned gifts. Legacy Society members are recognized in our Annual Report (your gift can remain anonymous) and receive special updates each year from the President and CEO.
Join the Legacy Society
To become a member of the Legacy Society, please complete the Letter of Intent for Estate Gifts (PDF) and return to the Office of Planned Giving. The letter of intent will serve as documentation of your gift and will help ensure that your gift is received by us and that it's used the way you want it to be used.
We are happy to provide you with bequest language to include in your estate plans or to discuss planned giving options that may be of interest to you. If you have already included Parkinson's Foundation in your estate plan, please let us know by completing the Letter of Intent so we can thank you for your generosity and enroll you as our newest Legacy Society member.
Please contact us for more information.
Meet our Legacy Society Members
Our donors have chosen to give back in extraordinary ways. Through estate planning, they have created meaningful, lasting legacies for future generations. Because of their generosity and foresight, Parkinson's Foundation can continue work towards advances in Parkinson's care and research.
Read their stories below:
Nancy Novick: Changing the Future of Parkinson's CareWhen Nancy Novick was diagnosed with Parkinson's disease (PD) in her 50s, she knew that she wanted to help others facing similar challenges.
Paul F. Oreffice: The Greatest RewardThere is a common perception that people who make planned gifts to an organization can do so thanks to vast wealth that is often inherited.
Robert A.M. Coppenrath: A Quest to Beat Parkinson'sResearchers Unraveling the Clues for a Parkinson's Cure